Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub

The laboratory gives researchers a training ground for state-of-the-art DNBSEQ technology to further precision diagnostics and treatments SAN JOSE, Calif., May 21, 2024 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced theMay 22 opening of its Customer E...

2024-05-21 21:00 1776

Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy

SUZHOU, China, May 21, 2024 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, proudly announces that its flagship program, RAG-01, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA). This notable a...

2024-05-21 20:00 1749

Cali Biosciences Announces Publication of Successful Phase 2 Study Results in Hernia

SAN DIEGO, May 21, 2024 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali Biosciences"), a biotechnology company dedicated to the research and development of innovative drugs, announced publication of "CPL‑01, an investigational long‑acting ropivacaine, demonstrates saf...

2024-05-21 17:52 1115

So-Young to Report First Quarter 2024 Financial Results on May 28, 2024

BEIJING, May 21, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financ...

2024-05-21 17:00 2089

NUS scientists discover a novel way of activating muscle cells' natural defences against cancer using magnetic pulses

This drug-free, non-invasive approach could open the doors for new developments in cancer therapy and cancer biomarker discovery SINGAPORE, May 21, 2024 /PRNewswire/ -- A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technolo...

2024-05-21 16:35 1554

Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024

NANJING, China, May 21, 2024 /PRNewswire/ -- The 10th European Stroke Organization Congress (ESOC), held inBasel, Switzerland from May 15 to 17, 2024 , showcased six studies on Sanbexin® (Edaravone and Dexborneol Concentrated Solution for Injection) and a new dosage form of sublingual tablets unde...

2024-05-21 15:52 1355

Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024

GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance

YONGIN, South Korea, May 21, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A. With this FDA clearance,...

2024-05-21 15:12 1478

ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative colitis

* Findings from the extended LIBERTY studies and associated post-hoc analysis support the long-term efficacy and safety of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab[1],[2] * Data from a post-hoc analysis of the LIBERTY-CD study showed that, despite affecting drug lev...

2024-05-21 12:01 1778

Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite

- From research to real-world impact: Lunit demonstrates Lunit INSIGHT's clinical safety, effectiveness, and efficiency in 100 papers SEOUL, South Korea, May 20, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

2024-05-20 21:00 2064

Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite

Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery

SHANGHAI, May 20, 2024 /PRNewswire/ -- Duoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess provider inChina, today announced a strategic partnership with Bioelectronica, a company focusing on developing tools for single-cell/single-bacteria research. This partnership aims to en...

2024-05-20 20:00 1835

Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery

HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director

SYDNEY, May 20, 2024 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg Hunt, former Australian Federal Minister for Health, to the HaemaLog...

2024-05-20 18:00 1742

GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval

YONGIN, South Korea, May 20, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval. With this approval, development of 'GC1130A' is expected to accelerate with multinational clinical trial...

2024-05-20 14:07 1511

Orion Health awarded Panda Health Partner status for its Orchestral Health Intelligence Platform

NEW YORK, May 19, 2024 /PRNewswire/ -- Orion Health , a global leader in digital health solutions, announced today that it has been awarded partner status byPanda Health for its Orchestral

2024-05-19 23:10 1871

Qilian International plans to adjust industrial investment

JIUQUAN, China, May 17, 2024 /PRNewswire/ -- Qilian International Holdings Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), a pharmaceutical and chemical products manufacturer headquartered inChina, today announced: In the past two years, Qilian International Holdings Group Limited has en...

2024-05-17 22:00 5683

Strengthening Bonds in "Momcozy Village": A Comprehensive Review of Momcozy's Mother's Day Campaign

NEW YORK, May 17, 2024 /PRNewswire/ -- In the spirit of Mother's Day, Momcozy, a global leader in maternal and infant care, has once again underscored its commitment to empowering mothers through its innovative "Momcozy Village" campaign

2024-05-17 22:00 2363

Sean Ha (Tae Kyoung Ha), the president of USA HoneyNaps, wins an award from South Korea's Ministry of Science and ICT

BOSTON, May 17, 2024 /PRNewswire/ -- Sean Ha (Tae Kyoung Ha), the president of HoneyNapsUSA, Inc., was awarded the 2023 Artificial Intelligence Industry Contributor prize bySouth Korea's Ministry of Science and ICT in recognition of his contribution to the development of artificial intelligence. ...

2024-05-17 21:47 4791

Sean Ha (Tae Kyoung Ha), the president of USA HoneyNaps, wins an award from South Korea's Ministry of Science and ICT

GV Announces Cooperation with Top 500 Company in China

TORONTO, May 17, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company and Red Sun...

2024-05-17 20:30 3348

OMRON Healthcare's Presence at Heart Rhythm 2024 in the U.S.

KYOTO, Japan, May 17, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko,Kyoto Prefecture, Japan, announced its presence at Heart Rhythm 2024, the Annual Meeting of the Heart Rhythm Society (HRS) in the U.S. At Heart Rhythm 2024, the Company will showcase its upper-arm blood pressure m...

2024-05-17 16:00 1793

Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference

* Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals ofZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab * The data underscores Celltrion's commitment to improving patient outcomes and advancing scientific understanding in th...

2024-05-17 12:01 1617

Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer

GEMBLOUX, Belgium, May 16, 2024 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment ofMark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43 yea...

2024-05-17 08:00 1390

1 ... 41 42 434445 46 47 ... 283